StocksFundsScreenerSectorsWatchlists
SYK

SYK - Stryker Corp Stock Price, Fair Value and News

337.55USD-1.58 (-0.47%)Market Closed

Market Summary

SYK
USD337.55-1.58
Market Closed
-0.47%

SYK Alerts

  • 1 major insider sales recently.

SYK Stock Price

View Fullscreen

SYK RSI Chart

SYK Valuation

Market Cap

128.4B

Price/Earnings (Trailing)

40.56

Price/Sales (Trailing)

6.26

EV/EBITDA

30.82

Price/Free Cashflow

40.93

SYK Price/Sales (Trailing)

SYK Profitability

Operating Margin

63.70%

EBT Margin

17.92%

Return on Equity

17.02%

Return on Assets

7.93%

Free Cashflow Yield

2.44%

SYK Fundamentals

SYK Revenue

Revenue (TTM)

20.5B

Rev. Growth (Yr)

11.78%

Rev. Growth (Qtr)

18.46%

SYK Earnings

Earnings (TTM)

3.2B

Earnings Growth (Yr)

103.02%

Earnings Growth (Qtr)

65.17%

Breaking Down SYK Revenue

Last 7 days

-3.8%

Last 30 days

-4.2%

Last 90 days

7.6%

Trailing 12 Months

15.3%

How does SYK drawdown profile look like?

SYK Financial Health

Current Ratio

1.58

Debt/Equity

0.59

Debt/Cashflow

0.34

SYK Investor Care

Dividend Yield

0.87%

Dividend/Share (TTM)

2.95

Shares Dilution (1Y)

0.38%

Diluted EPS (TTM)

8.25

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202319.0B19.5B19.9B20.5B
202217.4B17.6B17.9B18.4B
202114.7B16.2B16.7B17.1B
202015.0B14.1B14.2B14.4B
201913.9B14.2B14.5B14.9B
201812.7B13.0B13.3B13.6B
201711.8B12.0B12.1B12.4B
201610.1B10.5B10.9B11.3B
20159.7B9.8B9.8B9.9B
20149.1B9.3B9.5B9.7B
20138.7B8.8B8.9B9.0B
20128.5B8.5B8.5B8.7B
20117.5B7.8B8.1B8.3B
20106.9B7.0B7.2B7.3B
20096.7B6.6B6.6B6.7B
200806.2B6.5B6.7B
20070006.0B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Stryker Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 21, 2024
stiles spencer s
sold (taxes)
-1,340,710
353
-3,796
group president
Mar 21, 2024
fletcher robert s
sold (taxes)
-791,146
353
-2,240
vp, chief legal officer
Mar 21, 2024
boehnlein glenn s
acquired
-
-
256
vp, chief financial officer
Mar 21, 2024
stiles spencer s
acquired
-
-
203
group president
Mar 21, 2024
menon viju
sold (taxes)
-1,216,390
353
-3,444
group president
Mar 21, 2024
lobo kevin
sold (taxes)
-6,987,860
353
-19,785
chair and ceo
Mar 21, 2024
becker yin c
acquired
-
-
36.00
vp, chief corp affairs officer
Mar 21, 2024
becker yin c
sold (taxes)
-279,726
353
-792
vp, chief corp affairs officer
Mar 21, 2024
boehnlein glenn s
sold (taxes)
-1,961,970
353
-5,555
vp, chief financial officer
Mar 21, 2024
fink m kathryn
acquired
-
-
83.00
vp, chief hr officer

1–10 of 50

Which funds bought or sold SYK recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 15, 2024
St. Johns Investment Management Company, LLC
reduced
-3.35
241,229
1,797,220
0.86%
Apr 15, 2024
FRANKLIN STREET ADVISORS INC /NC
unchanged
-
139,000
852,000
0.06%
Apr 15, 2024
Octavia Wealth Advisors, LLC
reduced
-44.4
-164,653
325,672
0.05%
Apr 15, 2024
S.A. Mason LLC
added
1.72
187,575
1,057,510
0.64%
Apr 15, 2024
Sunbelt Securities, Inc.
reduced
-16.25
-78.00
178,780
0.02%
Apr 15, 2024
Wealth Alliance Advisory Group, LLC
unchanged
-
225,171
1,379,590
0.32%
Apr 15, 2024
JANICZEK WEALTH MANAGEMENT, LLC
added
3.81
17,006
87,741
0.02%
Apr 15, 2024
Sound Income Strategies, LLC
unchanged
-
759
4,652
-%
Apr 15, 2024
ERn Financial, LLC
added
0.96
214,394
1,663,630
0.29%
Apr 15, 2024
CIC Wealth, LLC
reduced
-35.00
-66,844
232,616
0.07%

1–10 of 50

Are Funds Buying or Selling SYK?

Are funds buying SYK calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own SYK
No. of Funds

Unveiling Stryker Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
8.20%
31,149,173
SC 13G/A
Feb 12, 2024
greenleaf trust
4.9%
18,723,395
SC 13G/A
Jan 29, 2024
blackrock inc.
6.6%
24,924,572
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
4.0%
14,929,245
SC 13G/A
Feb 10, 2023
greenleaf trust
5.3%
19,869,434
SC 13G/A
Feb 09, 2023
vanguard group inc
7.99%
30,246,178
SC 13G/A
Feb 01, 2023
blackrock inc.
6.5%
24,494,206
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
5.5%
21,156,776
SC 13G/A
Feb 11, 2022
greenleaf trust
5.4%
20,452,972
SC 13G/A
Feb 10, 2022
vanguard group inc
7.60%
28,652,681
SC 13G/A

Recent SEC filings of Stryker Corp

View All Filings
Date Filed Form Type Document
Mar 26, 2024
DEF 14A
DEF 14A
Mar 26, 2024
DEFA14A
DEFA14A
Mar 25, 2024
4
Insider Trading
Mar 25, 2024
4
Insider Trading
Mar 25, 2024
4
Insider Trading
Mar 25, 2024
4
Insider Trading
Mar 25, 2024
4
Insider Trading
Mar 25, 2024
4
Insider Trading
Mar 25, 2024
4
Insider Trading
Mar 25, 2024
4
Insider Trading

Peers (Alternatives to Stryker Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
189.6B
40.1B
-5.40% 4.53%
33.12
4.73
-8.12% -17.45%
66.7B
19.5B
-2.42% -9.87%
53.13
3.42
4.02% -22.04%
22.9B
3.9B
-2.94% -12.25%
51.49
5.93
3.42% 23.09%
20.1B
14.8B
-4.93% -7.94%
7.56
1.36
2.12% 209.17%
MID-CAP
9.2B
12.3B
-4.49% -14.03%
22
0.74
-2.44% -22.68%
9.2B
3.5B
-1.69% 15.70%
32.17
2.62
4.97% 18.89%
8.5B
2.7B
-12.27% -39.23%
-13.41
3.2
-4.68% 82.43%
6.4B
4.0B
-6.21% -24.72%
-47.49
1.61
1.10% 85.84%
3.4B
366.4M
-0.75% 15.36%
-565.58
9.37
33.86% 89.83%
2.3B
6.6B
-5.91% -4.69%
11.86
0.35
2.78% -0.87%
SMALL-CAP
1.3B
3.2B
-6.61% -18.37%
-1.88
0.4
7.73% -1066.14%
380.0M
166.7M
0.59% -11.05%
-4.6
2.28
6.67% -456.34%
260.4M
324.0M
21.04% -28.41%
-1.35
0.8
-3.19% -337.41%
48.2M
52.3M
-22.35% -53.67%
-2.57
0.92
17.61% 19.28%
3.8M
3.7M
-16.76% 269.23%
-0.31
1.01
5.77% 8.23%

Stryker Corp News

Latest updates
Defense World30 minutes ago
MarketWatch05 Apr 202407:00 am
Yahoo Finance29 Mar 202407:00 am
CNN26 Mar 202412:24 pm

Stryker Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue18.5%5,8154,9094,9964,7785,2024,4794,4934,2754,7014,1604,2943,9534,2623,7372,7643,5884,1313,5873,6503,5163,796
Cost Of Revenue20.6%2,1121,7511,8151,7621,9661,6971,6671,5411,6561,5181,5221,4441,5451,2761,2161,2571,4281,2571,2701,2331,340
Gross Profit17.3%3,7033,1583,1813,0163,2362,7822,8262,7343,0452,6422,7722,5092,7172,4611,5482,3312,7032,3302,3802,2832,456
Operating Expenses9.8%2,4462,2272,2162,2812,4221,9742,0542,2872,2262,0682,0402,0501,9681,6021,5681,6961,7591,7021,7671,7551,758
  S&GA Expenses14.1%1,9411,7011,7061,7811,7511,4551,5391,7101,7451,6021,5051,5751,5621,2441,2251,3301,3801,2911,2821,4031,431
  R&D Expenses-0.8%350353346339326364351413331306310288255242233254254246246225221
EBITDA Margin-0.22*-0.20*0.19*0.18*0.19*0.17*0.17*0.17*0.17*0.19*0.16*0.18*0.20*0.19*0.22*0.21*0.20*0.20*0.21*-
Income Taxes-53.1%83.0017716187.00198-64.0063.0095.0057.0070.0065.00103159-4.0097.0021111585.0068.00-1,411
Earnings Before Taxes41.1%1,226869899679761816720386757495662367671780-87.00590936581565480657
EBT Margin11.1%0.18*0.16*0.16*0.16*0.15*0.15*0.13*0.13*0.13*0.13*0.15*0.12*0.14*0.16*0.14*0.18*0.17*0.16*0.16*--
Net Income65.2%1,143692738592563816656323662438592302568621-83.004937254664804122,068
Net Income Margin18.8%0.15*0.13*0.14*0.14*0.13*0.14*0.12*0.12*0.12*0.11*0.13*0.10*0.11*0.12*0.11*0.14*0.14*0.24*0.25*--
Free Cashflow53.3%1,38390253631581575138684.007948037723691,072760511447536466349--
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets4.9%39,91238,04237,40936,83036,88435,98336,03236,13734,63134,14533,69833,45534,33032,28631,48329,44030,16726,65926,35425,93727,229
  Current Assets13.3%12,51811,04510,15110,15510,2759,3188,8258,72510,0179,4609,0328,9799,70713,54512,80110,73611,0588,5668,1857,8889,733
    Cash Equivalents59.7%2,9711,8601,4011,6711,8441,4201,0441,4582,9442,5632,2412,2382,9437,0836,5393,9644,3371,9481,7541,6743,616
  Inventory-0.8%4,8434,8834,5934,3333,9953,8833,7493,5253,3143,4343,4313,4733,4943,4593,4423,3592,9803,2693,1983,0642,955
  Net PPE3.5%3,2153,1063,0823,0372,9702,7982,8032,7932,8332,7462,7382,7102,7522,5292,5272,6072,5672,4602,3872,2972,291
  Goodwill0.7%15,24315,13815,17214,84914,88014,99315,11515,22812,91812,89312,80212,80312,7789,1289,0749,0259,0698,7048,7621148,563
Liabilities5.9%21,31920,13720,04819,93520,26819,52020,35821,09119,75419,96719,87819,95321,24619,30018,72916,32517,36014,34414,41114,24415,499
  Current Liabilities6.2%7,9217,4586,5845,8666,3034,5714,4044,4084,5494,4494,2523,9535,0414,6894,4054,1624,4003,9213,9463,7134,807
  Long Term Debt5.0%10,90110,38211,14911,85711,85712,75113,37413,88512,47212,62912,73413,05913,23012,00811,8119,40410,2317,8897,9747,9508,486
    LT Debt, Non Current5.0%10,90110,38211,14911,85711,85712,75113,37413,88512,47212,62912,73413,05913,23012,00811,8119,40410,2317,8897,9747,9508,486
Shareholder's Equity3.8%18,59317,90538.0038.0016,61616,46313,93338.0014,87714,17838.0038.0038.0012,9861,70638.0011,74812,3151,56937.0011,730
  Retained Earnings5.3%16,77115,93315,52615,07214,76514,48613,93313,54013,48013,08112,88112,52512,46212,12911,72512,02411,74811,23810,96710,68310,765
  Additional Paid-In Capital0.8%2,2002,1832,1272,0902,0342,0281,9891,9471,8901,8751,8441,8061,7411,7361,7061,6761,6281,5931,5691,5381,559
Accumulated Depreciation2.6%3,1293,0493,0052,9332,8352,7362,7462,7392,6652,6942,6242,4962,4302,3102,2482,1692,1472,1432,0912,0451,986
Shares Outstanding-0.1%380380379379378378378378377377377376376375375375374374374--
Float---109,723---70,965---91,942---63,413---71,863--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations45.5%1,5281,0506884451,0038895292031,0009338784521,2378296205917356295143131,046
  Share Based Compensation-23.1%40.0052.0039.0074.0028.0033.0036.0071.0030.0034.0039.0068.0027.0029.0030.0056.0032.0032.0028.0035.0032.00
Cashflow From Investing-4.8%-152-145-533-132-16272.00-152-2,682-314-247-202-96.00-4,352-69.00-117-163-719-186-247-303-1,628
Cashflow From Financing32.2%-286-422-405-481-446-543-753993-288-348-676-1,053-1,057-2422,056-7682,363-225-188-1,9472,280
  Dividend Payments0%285285285284263263263262237238237238216216216215193195195195175
  Buy Backs--------------------307-

SYK Income Statement

2023-12-31
Consolidated Statements Of Earnings - USD ($)
$ in Thousands, shares in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Net sales$ 20,498,000$ 18,449,000$ 17,108,000
Cost of sales7,440,0006,871,0006,140,000
Gross profit13,058,00011,578,00010,968,000
Research, development and engineering expenses1,388,0001,454,0001,235,000
Selling, general and administrative expenses7,129,0006,455,0006,427,000
Recall charges, net18,000(15,000)103,000
Amortization of intangible assets635,000627,000619,000
Goodwill impairment0216,0000
Total operating expenses9,170,0008,737,0008,384,000
Operating income3,888,0002,841,0002,584,000
Other income (expense), net(215,000)(158,000)(303,000)
Earnings before income taxes3,673,0002,683,0002,281,000
Income taxes508,000325,000287,000
Net earnings$ 3,165,000$ 2,358,000$ 1,994,000
Net earnings per share of common stock:   
Basic net earnings per share of common stock (in dollars per share)$ 8.34$ 6.23$ 5.29
Diluted net earnings per share of common stock (in dollars per share)$ 8.25$ 6.17$ 5.21
Weighted-average shares outstanding (in millions):   
Basic (in shares)379.6378.2377.0
Effect of dilutive employee stock compensation (in shares)4.14.05.3
Diluted (in shares)383.7382.2382.3

SYK Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets  
Cash and cash equivalents$ 2,971$ 1,844
Marketable securities8284
Accounts receivable, less allowance of $182 ($154 in 2022)3,7653,565
Inventories:  
Materials and supplies1,2421,006
Work in process330348
Finished goods3,2712,641
Total inventories4,8433,995
Prepaid expenses and other current assets857787
Total current assets12,51810,275
Property, plant and equipment:  
Land, buildings and improvements1,6921,739
Machinery and equipment4,6524,066
Total property, plant and equipment6,3445,805
Less allowance for depreciation3,1292,835
Property, plant and equipment, net3,2152,970
Goodwill15,24314,880
Other intangibles, net4,5934,885
Noncurrent deferred income tax assets1,6701,410
Other noncurrent assets2,6732,464
Total assets39,91236,884
Current liabilities  
Accounts payable1,5171,413
Accrued compensation1,4781,149
Income taxes391292
Dividend payable304284
Accrued product liabilities209230
Accrued expenses and other liabilities1,9281,744
Current maturities of debt2,0941,191
Total current liabilities7,9216,303
Long-term debt, excluding current maturities10,90111,857
Income taxes567641
Other noncurrent liabilities1,9301,467
Total liabilities21,31920,268
Shareholders' equity  
Common stock, $0.10 par value3838
Additional paid-in capital2,2002,034
Retained earnings16,77114,765
Accumulated other comprehensive loss(416)(221)
Total shareholders' equity18,59316,616
Total liabilities & shareholders' equity$ 39,912$ 36,884
Common stock, par value (in dollars per share)$ 0.10$ 0.10
SYK
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
 CEO
 WEBSITEstryker.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES51000

Stryker Corp Frequently Asked Questions


What is the ticker symbol for Stryker Corp? What does SYK stand for in stocks?

SYK is the stock ticker symbol of Stryker Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Stryker Corp (SYK)?

As of Tue Apr 16 2024, market cap of Stryker Corp is 128.36 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SYK stock?

You can check SYK's fair value in chart for subscribers.

What is the fair value of SYK stock?

You can check SYK's fair value in chart for subscribers. The fair value of Stryker Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Stryker Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SYK so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Stryker Corp a good stock to buy?

The fair value guage provides a quick view whether SYK is over valued or under valued. Whether Stryker Corp is cheap or expensive depends on the assumptions which impact Stryker Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SYK.

What is Stryker Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 16 2024, SYK's PE ratio (Price to Earnings) is 40.56 and Price to Sales (PS) ratio is 6.26. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SYK PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Stryker Corp's stock?

In the past 10 years, Stryker Corp has provided 0.168 (multiply by 100 for percentage) rate of return.